The FDA has granted fast-track designation to nipocalimab for the treatment of Sjögren’s disease, according to a press ...

FDA grants Fast Track designation to Johnson & Johnson’s investigational therapy nipocalimab for the treatment of moderate-to-severe Sjögren’s disease, which could be the first targeted therapy ever ...

New agents targeting endocrine therapy and CDK4/6 resistance in hormone receptor–positive breast cancer are in development.

Thane Wettig; Interim Chief Executive Officer, Chief Commercial Officer; FibroGen Inc. David Delucia; Vice Presi ...

The leading Pulmonary Arterial Hypertension Companies such as Merck Sharp & Dohme, Acceleron Pharma, Liquidia Technologies, ...

Whether you are watching television, scrolling through Instagram, or catching up with an old friend, the topic of weight loss ...

Whether with shots, gum or espressos, players are getting their caffeine fix more than ever to boost performance ...

This paper presents the important finding that BNIP3/NIX, a mitophagy receptor, and its binding to ATG18 are required for mitophagy during muscle cell reorganization in Drosophila. Although the ...

Myrobalan Therapeutics, a biotechnology company developing potent, selective, and brain-penetrant oral small-molecule therapies to restore brain function, today announced a grant of over $850,000 from ...

DeAndre Hopkins moved from one two-time MVP quarterback to another. “Once we found out that I wouldn’t be back in Kansas City ...

The FC 25 FUT Fantasy FC tracker has received its first set of upgrades, with Eden Hazard and Joao Felix among its early winners. This EA FC 25 Ultimate Team promo awards boosts for real-world ...

Millions of people have lost weight on GLP-1s. But the drugs can also cause significant loss of muscle mass. The fitness industry is responding with tailored workouts that cater to these clients ...